Association between genetic polymorphisms of Toll-like receptor 2 (TLR2) and schizophrenia in the Korean population

Gene

Volumn 526, Issue 2, 2013, Pages 182-186

  Kang, Won Sub ^a   Park, Jin Kyung ^a   Lee, Sang Min ^a   Kim, Su Kang ^a   Park, Hae Jeong ^a   Kim, Jong Woo ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Immunological dysregulation; Poor concentration; Schizophrenia; TLR2 gene

Indexed keywords

TOLL LIKE RECEPTOR 2;

ADULT; ALLELE; ARTICLE; AUDITORY HALLUCINATION; CHECKLIST; CLINICAL ASSESSMENT; CODOMINANCE; COGNITION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; PERSECUTORY DELUSION; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

CENTRAL NERVOUS SYSTEM; CI; CNS; CONFIDENCE INTERVAL; HARDY-WEINBERG EQUILIBRIUM; HWE; IMMUNOLOGICAL DYSREGULATION; LD; LINKAGE DISEQUILIBRIUM; ODDS RATIOS; OPCRIT; OPERATION CRITERIA CHECKLIST FOR PSYCHOTIC ILLNESS; ORS; POOR CONCENTRATION; SANS; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS; SCHIZOPHRENIA; SD; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; STANDARD DEVIATION; TLR2; TLR2 GENE; TNF-Α; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-Α;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; SCHIZOPHRENIA; TOLL-LIKE RECEPTOR 2;

EID: 84880752699     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.04.058     Document Type: Article

References (33)

1. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Arch. Gen. Psychiatry 1982, 39:784-788.
2. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
3. Bjørnvold M., et al. A TLR2 polymorphism is associated with type 1 diabetes and allergic asthma. Genes Immun. 2009, 10:181-187.
4. Chen J., et al. Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine 2011, 29:706-711.
5. Chen K.H., et al. Identification of haplotype tag SNPs within the entire TLR2 gene and their clinical relevance in patients with major trauma. Shock 2011, 35:35-41.
6. Collins F.S., Brooks L.D., Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res. 1998, 8:1229-1231.
7. Du X., et al. Systemic stimulation of TLR2 impairs neonatal mouse brain development. PLoS One 2011, 6:e19583.
8. Gabriel S.B., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
9. Hanke M.L., Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin. Sci. (Lond.) 2011, 121:367-387.
10. Hong J., et al. Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death. J. Biol. Chem. 2010, 285:39447-39457.
11. Hunt R., Sauna Z.E., Ambudkar S.V., Gottesman M.M., Kimchi-Sarfaty C. Silent (synonymous) SNPs: should we care about them?. Methods Mol. Biol. 2009, 578:23-39.
12. Junjie X., et al. The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility. BMC Cancer 2012, 12:57.
13. Kielian T. Toll-like receptors in central nervous system glial inflammation and homeostasis. J. Neurosci. Res. 2006, 83:711-730.
14. Kielian T., Esen N., Bearden E.D. Toll-like receptor 2 (TLR2) is pivotal for recognition of S. aureus peptidoglycan but not intact bacteria by microglia. Glia 2005, 49:567-576.
15. Lewis C.M. Genetic association studies: design, analysis and interpretation. Brief. Bioinform. 2002, 3:146-153.
16. Lien Y.J., et al. The multidimensionality of schizotypy in nonpsychotic relatives of patients with schizophrenia and its applications in ordered subsets linkage analysis of schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010, 153B:1-9.
17. Mattson M.P., Culmsee C., Yu Z., Camandola S. Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 2000, 74:443-456.
18. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch. Gen. Psychiatry 1991, 48:764-770.
19. McKernan D.P., Dennison U., Gaszner G., Cryan J.F., Dinan T.G. Enhanced peripheral Toll-like receptor responses in psychosis: further evidence of a pro-inflammatory phenotype. Transl. Psychiatry 2011, 1. 10.1038/tp.2011.37.
20. Meyer U., Schwarz M.J., Muller N. Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond. Pharmacol. Ther. 2011, 132:96-110.
21. Miller B.J., Buckley P., Seabolt W., Mellor A., Kirkpatrick B. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol. Psychiatry 2011, 70:663-671.
22. Monji A., et al. Neuroinflammation in schizophrenia especially focused on the role of microglia. Prog. Neuropsychopharmacol Biol. Psychiatry 2011, 10.1016/j.pnpbp.2011.12.002.
23. Okun E., et al. Toll-like receptors in neurodegeneration. Brain Res. Rev. 2009, 59:278-292.
24. Okun E., et al. TLR2 activation inhibits embryonic neural progenitor cell proliferation. J. Neurochem. 2010, 114:462-474.
25. Okun E., Griffioen K.J., Mattson M.P. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011, 34:269-281.
26. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
27. Ovsyannikova I.G., et al. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum. Genet. 2011, 130:547-561.
28. Purdue M.P., et al. A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma. Carcinogenesis 2009, 30:275-281.
29. Rolls A., et al. Toll-like receptors modulate adult hippocampal neurogenesis. Nat. Cell Biol. 2007, 9:1081-1088.
30. Strous R.D., Shoenfeld Y. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited. J. Autoimmun. 2006, 27:71-80.
31. Takahashi M., et al. Toll-like receptor 2 gene polymorphisms associated with aggressive periodontitis in Japanese. Open Dent. J. 2011, 5:190-194.
32. Tang S.C., et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13798-13803.
33. van Berckel B.N., et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 2008, 64:820-822.